On the recordSeptember 26, 2016
I’ve sent a letter to the Federal Trade Commission on this issue to investigate whether or not Indivior has engaged in unlawful behavior to delay the approval of cheaper generic competition.
Source
congress.govI’ve sent a letter to the Federal Trade Commission on this issue to investigate whether or not Indivior has engaged in unlawful behavior to delay the approval of cheaper generic competition.
Markey is urging an investigation into Indivior's actions affecting drug competition.
Share
More from Ed Markey
Sanctions on North Korea should target the oppressive Kim regime and its dangerous nuclear ambitions—not its vulnerable civilians who lack access to essential services and lifesaving care.
Congress must pass my Youth AI Privacy Act to protect kids using AI chatbots and pass COPPA 2.0 to update my original law.
Over the past two years, my office has been working closely with the family of Robert Gilman – a Massachusetts resident and former Marine who has been wrongfully detained in Russia on questionable charges for 1,666 days.